David C. Hanley - 19 Nov 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship: CHIEF TECHNICAL OPERATIONS
Issuer ticker: NUVB
Reported as of: 19 Nov 2025
Net transaction value: -$1,053,680
SEC form: 4
Accepted by SEC: 21 Nov 2025, 16:05:06 UTC
Prior SEC filing: 04 Mar 2025
Next SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen Dang, Attorney-in-Fact

Key filing fact

David C. Hanley filed Form 4 for Nuvation Bio Inc. (NUVB) on 21 Nov 2025.

Key facts

This page summarizes David C. Hanley's Form 4 filing for Nuvation Bio Inc. (NUVB).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Nov 2025, 16:05.

Change

Previous filing in this sequence was filed on 04 Mar 2025.
Current net transaction value: -$1,053,680.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001865826 Primary reporting owner

Hanley David C.

Relationship: CHIEF TECHNICAL OPERATIONS
Address: C/O NUVATION BIO, INC., 1500 BROADWAY, SUITE 1401, NEW YORK
Signature: /s/ Stephen Dang, Attorney-in-Fact
Signature date: 21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Options Exercise

Transaction value: $374,000
Shares: +200,000
Change %: +833%
Price: $1.87
Shares after: 224,000
Date: 19 Nov 2025
Ownership: Direct
Footnotes: F1

NUVB transaction

Class A Common Stock

Sale

Transaction value: $1,427,680
Shares: -200,000
Change %: -89%
Price: $7.14
Shares after: 24,000
Date: 19 Nov 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -200,000
Change %: -40%
Price: $0.000000
Shares after: 300,000
Date: 19 Nov 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 200,000
Exercise price: $1.87
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes 3,000 shares acquired on each of May 19, 2025 and November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan.

Footnote F2

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.045 to $7.260. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.